MAXHEALTH.NS Stock Analysis
MA
Avoid
Based on Eyestock quantitative analysis, MAXHEALTH.NS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Market cap $B
1.989
Dividend yield
0.29 %
Shares outstanding
971.91 B
Max Healthcare Institute Ltd. engages in the management and operation of hospitals and specialty clinics. The firm operates through a single segment, which is Medical and Healthcare Services. The company provides a wide array of services ranging from primary to quaternary care, including advanced cardiac care, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The firm also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services as well as radiology, imaging and emergency services. The firm has two strategic business units (SBUs): Max Lab and Max@Home. The company owns and operates hospitals and medical care facilities in the Delhi national capital region (NCR), Punjab, Haryana, Uttar Pradesh, Uttarakhand and Maharashtra. The company has over 13 healthcare facilities, including five hospitals and three medical centers.